Zusammenfassung
Hintergrund
Prurigo wird bei vielen dermatologischen, aber auch systemischen und neurologischen Erkrankungen beobachtet.
Fragestellung
Welche Erkrankungen aus dem Bereich Dermatologie, innere Medizin und Neurologie sind mit einer Prurigo nodularis verknüpft?
Material und Methode
Beschreibung der verschiedenen Prurigo-assoziierten Krankheitsentitäten inklusive pathogenetischer und therapeutischer Aspekte.
Ergebnisse
Im Bereich der klassischen Hauterkrankungen wird eine Prurigo nodularis vor allem bei der atopischen Dermatitis, aber auch bei Lymphomen der Haut sowie kutanen mykobakteriellen Infektionen und bullösen Erkrankungen beobachtet. Generell tritt eine Prurigo nodularis ausschließlich in Verbindung mit chronischem Pruritus auf, oft im Zusammenhang mit fortgeschrittenen Nieren- oder Lebererkrankungen. Darüber hinaus können auch hämatologische und metabolische Krankheiten (solide Tumoren, Lymphome, Diabetes mellitus etc.) mit einer Prurigo nodularis verknüpft sein. Bezüglich der Pathophysiologie der Prurigo sind nur Teilaspekte bekannt. Die Behandlung der Prurigo nodularis ist schwierig und meist multimodal.
Schlussfolgerungen
Die Prurigo nodularis ist eine Hautmanifestation des chronischen Pruritus bei vielen verschiedenen Erkrankungen aus verschiedenen Bereichen der Medizin. Dies macht einen interdisziplinären diagnostischen und therapeutischen Ansatz erforderlich.
Abstract
Background
Prurigo is seen in various dermatological diseases, but also in systemic and neurological diseases.
Objectives
Which diseases in dermatology, internal medicine and neurology are linked to prurigo nodularis?
Material and methods
We describe the various entities that are associated with prurigo and discuss pathogenetic and therapeutic implications.
Results
In dermatology prurigo nodularis is most frequently seen in atopic dermatitis, but also in cutaneous lymphomas, mycobacterial skin infections and bullous diseases. Among systemic diseases, prurigo nodularis frequently is associated with pruritus of chronic renal or hepatic diseases. Prurigo nodularis is also seen in hematological and metabolic diseases (such as solid tumors, lymphoma, diabetes mellitus). The pathophysiology of prurigo is only partly understood. Treatment of prurigo nodularis is often challenging and a multimodal approach is advisable.
Conclusion
Prurigo nodularis is a skin manifestation of chronic pruritus caused by various diseases in dermatology, internal medicine and neurology. An interdisciplinary approach should be taken for diagnosis and therapy.
Literatur
Raap U, Kapp A, Wedi B, Stander S (2010) Pruritus and urticaria. Hautarzt 61(9):737–742
Iking A, Grundmann S, Chatzigeorgakidis E et al (2013) Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients. J Eur Acad Dermatol Venereol 27(5):550–557
Pugliarello S, Cozzi A, Gisondi P, Girolomoni G (2011) Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges 9(1):12–20
Tanaka M, Aiba S, Matsumura N et al (1995) Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic. Dermatology 190(4):269–276
Seeburger J, Anderson-Wilms N, Jacobs R (1993) Lennert’s lymphoma presenting as prurigo nodularis. Cutis 51(5):355–358
Saporito L, Florena AM, Colomba C et al (2009) Prurigo nodularis due to Mycobacterium tuberculosis. J Med Microbiol 58(Pt 12):1649–1651
Mattila JO, Vornanen M, Katila ML (1997) Histopathological and bacteriological findings in prurigo nodularis. Acta Derm Venereol 77(1):49–51
Mattila JO, Vornanen M, Vaara J, Katila ML (1996) Mycobacteria in prurigo nodularis: the cause or a consequence? J Am Acad Dermatol 34(2 Pt 1):224–228
Weigelt N, Metze D, Stander S (2010) Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients. J Cutan Pathol 37(5):578–586
Cifuentes L, Kiritsi D, Chen W et al (2013) A case of junctional epidermolysis bullosa with prurigo-like lesions and reduction of collagen XVII and filaggrin. Br J Dermatol 169(1):195–198
Cliff S, Holden CA (1997) Pemphigoid nodularis: a report of three cases and review of the literature. Br J Dermatol 136(3):398–401
Gilchrest GA, Stern RS, Steinman TI et al (1982) Clinical features of pruritus among patients undergoing maintenance hemodialysis. Arch Dermatol 118:154–156
Droge U, Mautner V, Hoting E (1986) Differenzierung von Pruritusqualitäten. Dtsch Derm 34:919
Mathur VS, Lindberg J, Germain M et al (2010) A longitudinal study of uremic pruritus in hemodialysis patients. Clin J Am Soc Nephrol 5:1410–1419
Mettang T, Kremer A (2014) Uremic pruritus. Kidney Int (im Druck)
Virga G, Visentin I, La Milia V, Bonadonna A (2002) Inflammation and pruritus in haemodialysis patients. Nephrol Dial Transplant 17:2164–2169
Kimmel M, Alscher DM, Dunst R et al (2006) The role of micro-inflammation in the pathogenesis of uraemic pruritus in haemodialysis patients. Nephrol Dial Transplant 21:749–755
Weisshaar E, Dunker N, Rohl FW, Gollnick H (2004) Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients. Exp Dermatol 13:298–304
Szepietowski JC, Reich A, Schwartz RA (2004) Uraemic Xerosis. Nephrol Dial Transplant 19:2709–2712
Kuypers DR, Claes K, Evenepoel P et al (2004) A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 19:1895–1901
Peer G, Kivity S, Agami O et al (1996) Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 348:1552–1554 (14)
Pauli-Magnus C, Mikus G, Alscher DM et al (2000) Naltrexone does not relieve uremic pruritus: results of a randomized, placebo-controlled crossover-study. J Am Soc Nephrol 11:514–519
Wikström B, Gellert R, Ladefoged SD et al (2005) μ-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 16:3742–3747
Kumagai H, Ebata T, Takamori K et al (2010) Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-cpntrolled study. Nephrol Dial Transplant 25:1251–1257
Razeghi E, Eskandari D, Ganji MR et al (2009) Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail 31:85–90
Rayner H, Baharani J, Smith S et al (2012) Uraemic pruritus: relief of itching by gabapentin and pregabalin. Nephron Clin Pract 122:75–79
Tan JK, Haberman HF, Coldman AJ (1991) Identifying effective treatments for uremic pruritus. J Am Acad Dermatol 25:811–818
Kremer AE, Oude Elferink RP, Beuers U (2011) Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol 35:89–97
Kremer AE, Dijk R van, Leckie P et al (2012) Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions. Hepatology 56:1391–1400
Kilic A, Gul U, Soylu S (2007) Skin findings in internal malignant diseases. Int J Dermatol 46(10):1055–1060
Dereure O, Guilhou JJ (2000) Multifocal hepatocellular carcinoma presenting as prurigo: two cases. Br J Dermatol 143:1331–1332
Lin JT, Wang WH, Yen CC et al (2002) Prurigo nodularis as initial presentation of metastatic transitional cell carcinoma of the bladder. J Urol 168:631–632
Afifi Y, Aubin F, Puzenat E et al (2004) Pruritus sine materia: a prospective study of 95 patients. Rev Med Interne 25:490–493
Abdel-Naser MB, Gollnick H, Orfanos CE (1993) Aquagenic pruritus as a presenting symptom of polycythemia vera. Dermatology 187(2):130–133
Goldman B, Koh H (1994) Pruritus and malignancy. In: Bernhard J (Hrsg) Itch: mechanisms and management of pruritus. McGraw-Hill, New York, S 299–319
Shelnitz LS, Paller AS (1990) Hodgkin’s disease manifesting as prurigo nodularis. Pediatr Dermatol 7(2):136–139
Seshadri P, Rajan SJ, George IA, George R (2009) A sinister itch: prurigo nodularis in Hodgkin lymphoma. J Assoc Physicians India 57:715–716
Schweda K, Hainz M, Loquai C et al (2014) Prurigo nodularis as index symptom of (non-Hodgkin) lymphoma: ultrasound as a helpful diagnostic tool in dermatological disorders of unknown origin. Int J Dermatol. doi:10.1111/ijd.12022 (Epub ahead of print)
Adams S (1989) Iron deficiency, serum ferritin, generalized pruritus and systemic disease: a case control study. Br J Dermatol 121
Akashi R, Ishiguro N, Shimizu S, Kawashima M (2011) Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J Dermatol 38(8):761–766
Grundmann SA, Stratmann E, Brehler R et al (2011) Lactase deficiency: a potential novel etiological factor in chronic pruritus of unknown origin. Acta Derm Venereol 91(6):698–703
Mishkin D, Sablauskas L, Yalovsky M, Mishkin S (1997) Fructose and sorbitol malabsorption in ambulatory patients with functional dyspepsia: comparison withlactose maldigestion/malabsorption. Dig Dis Sci 42(12):2591–2598
Wallengren J (2004) Prurigo: diagnosis and management. Am J Clin Dermatol 5(2):85–95
De D, Dogra S, Kanwar AJ (2007) Prurigo nodularis in healed herpes zoster scar: an isotopic response. J Eur Acad Dermatol Venereol 21(5):711–712
Magand F, Nacher M, Cazorla C et al (2011) Predictive values of prurigo nodularis and herpes zoster for HIV infection and immunosuppression requiring HAART in French Guiana. Trans R Soc Trop Med Hyg 105:401–404
Kremer AE, Beuers U, Oude-Elferink RP, Pusl T (2008) Pathogenesis and treatment of pruritus in cholestasis. Drugs 68:2163–2182
- Einhaltung ethischer Richtlinien
Interessenkonflikt. T. Mettang, A. Vonend und Ulrike Raap geben an, dass kein Interessenkonflikt besteht. Der Beitrag enthält keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mettang, T., Vonend, A. & Raap, U. Prurigo nodularis bei Dermatosen und systemischen Erkrankungen. Hautarzt 65, 697–703 (2014). https://doi.org/10.1007/s00105-014-2755-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00105-014-2755-x